Catherine Coste - 13 Dec 2024 Form 4 Insider Report for BIOMERICA INC (BMRA)

Reporting relationship: Director
Issuer ticker: BMRA
Reported as of: 13 Dec 2024
Net transaction value: +$26,350
SEC form: 4
Accepted by SEC: 17 Dec 2024, 19:30:05 UTC
Prior SEC filing: 14 Dec 2023
Next SEC filing: 20 Mar 2025
Source filing: View source filing
Reporting owner signature: /s/ Catherine Coste

Key filing fact

Catherine Coste filed Form 4 for BIOMERICA INC (BMRA) on 17 Dec 2024.

Key facts

This page summarizes Catherine Coste's Form 4 filing for BIOMERICA INC (BMRA).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 17 Dec 2024, 19:30.

Change

Previous filing in this sequence was filed on 14 Dec 2023.
Current net transaction value: +$26,350.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BMRA transaction

Common stock

Award

Transaction value: $26,350
Shares: +85,000
Change %: +194%
Price: $0.3100
Shares after: 128,790
Date: 13 Dec 2024
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on the one year anniversary of December 13, 2024, provided the reporting person remains in continuous service before the vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer.